Phase 1/2a study of concomitant radiotherapy with olaparib and temozolomide in unresectable high-grade glioma patients: Final results from the phase 2a step (OLA-TMZ-RTE-01).
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Dinu Stefan, Justine Lequesne, Pierre Kubicek, Sunyach Marie, Elisabeth Moyal, Julian Jacob, Fontanilles Maxime, Julien Geffrelot, Mathieu Boone, Jeanne Riverain, Mathilde Ducloie, Grégoire Braux, Joelle Lacroix, Fernand Missohou, Maxime Faisant, Evelyne Emery, Edwina Girard, Jean-Michel Grellard, Paul Lesueur, Benedicte Clarisse
Institutions: Centre François Baclesse, Institut de Cancérologie de l'Ouest, Centre Léon Bérard, Institut universitaire du cancer de Toulouse Oncopole, Université de Toulouse, Pitié-Salpêtrière Hospital, Centre Henri Becquerel, Centre Hospitalier Universitaire Amiens-Picardie, Centre Hospitalier Universitaire de Caen Normandie, Centre Hospitalier de Bretagne Sud
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162567623